In vitro studies of Flemish, Dutch, and wild-type β-amyloid provide evidence for two-staged neurotoxicity

Neurobiology of Disease

Volumn 11, Issue 2, 2002, Pages 330-340

  Kumar Singh, Samir ^a   Julliams, Ann ^a   Nuydens, Rony ^b   Ceuterick, Chantal ^c   Labeur, Christine ^d   Serneels, Sally ^a   Vennekens, Krist'l ^a   Van Osta, Peter ^b   Geerts, Hugo ^b   De Strooper, Bart ^e   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid ; Cerebral amyloid angiopathy; Neurotoxicity; Phosphorylation; SH SY5Y cells; Tau

Indexed keywords

ACTIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; TAU PROTEIN; TUBULIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL NECROSIS; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; STROKE;

EID: 0036966278     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0529     Document Type: Article

References (41)

1. Ancolio, K., Dumanchin, C., Barelli, H., Warter, J. M., Brice, A., Campion, D., Frebourg, T., & Checler, F. (1999) Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 β Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96, 4119-4124.
2. Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
3. Clements, A., Walsh, D. M., Williams, C. H., & Allsop, D. (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide. Neurosci. Lett. 161, 17-20.
4. Cras, P., van Harskamp, F., Hendriks, L., Ceuterick, C., van Duijn, C. M., Stefanko, S. Z., Hofman, A., Kros, J. M., Van Broeckhoven, C., & Martin, J. J. (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala β Gly mutation. Acta Neuropathol. 96, 253-260.
5. Davis, J., & Van Nostrand, W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc. Natl. Acad. Sci. USA 93, 2996-3000.
6. Davis-Salinas, J., & Van Nostrand, W. E. (1995) Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270, 20887-20890.
7. De Jonghe, C., Zehr, C., Yager, D., Prada, C. M., Younkin, S., Hendriks, L., Van Broeckhoven, C., & Eckman, C. B. (1998) Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol. Dis. 5, 281-286.
8. De Strooper, B., Umans, L., Van Leuven, F., & Van Den Berghe, H. (1993) Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): Cleavage of APP occurs in a late compartment of the default secretion pathway. J. Cell Biol. 121, 295-304.
9. Demeester, N., Mertens, C., Caster, H., Goethals, M., Vandekerckhove, J., Rosseneu, M., & Labeur, C. (2001) Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides. Eur. J. Neurosci. 13, 2015-2024.
10. Grabowski, T. J., Cho, H. S., Vonsattel, J. P., Rebeck, G. W., & Greenberg, S. M. (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49, 697-705.
11. Haass, C., Hung, A. Y., Selkoe, D. J., & Teplow, D. B. (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 17741-17748.
12. Hardy, J. (1997) Amyloid, the presenilins and Alzheimer disease. Trends Neurol. Sci. 20, 154-159.
13. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884.
14. Hendriks, L., van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J.-J., Hofman, A., & Van Broeckhoven, C. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet. 1, 218-221.
15. Julliams, A., Vanderhoeven, I., Kuhn, S., Van Broeckhoven, C., & De Jonghe, C. (1999) No influence of presenilin1 I143T and G384A mutations on endogenous tau phosphorylation in human and mouse neuroblastoma cells. Neurosci. Lett. 269, 83-86.
16. Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'Dahl, S., Nemens, E., White, J. A., Sadovnick, A. D., Ball, M. J., Kaye, J., Warren, A., McInnis, M., Antonarakis, S. E., Korenberg, J. R., Sharma, V., Kukull, W., Larson, E., Heston, L. L., Martin, G. M., Bird, T. D., & Schellenberg, G. D. (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am. J. Hum. Genet. 51, 998-1014.
17. Kumar-Singh, S., Cras, P., Wang, R., Kros, J. M., van Swieten, J. C., Lubke, U., Ceuterick-de Groote, C., Serneels, S., Vennekens, K., Timmermans, J.-P., Van Marck, E., Martin, J.-J., van Duijn, C., and Van Broeckhoven, C. (2002) Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am. J. Pathol. 161, 507-520.
18. Kumar-Singh, S., De Jonghe, C., Cruts, M., Kleinert, R., Wang, R., Mercken, M., De Strooper, B., Vanderstichele, H., Lofgren, A., Vanderhoeven, I., Backhovens, H., Vanmechelen, E., Kroisel, P. M., & Van Broeckhoven, C. (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated abeta(42) in Alzheimer's disease. Hum. Mol. Genet. 9, 2589-2598.
19. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., & Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
20. Lambert, M. P., Stevens, G., Sabo, S., Barber, K., Wang, G., Wade, W., Krafft, G., Snyder, S., Holzman, T. F., & Klein, W. L. (1994) Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39, 377-385.
21. Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3, 16-32.
22. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T., Luyendijk, W., & Frangione, B. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126.
23. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862.
24. Maat-Schieman, M. L., van Duinen, S. G., Bornebroek, M., Haan, J., & Roos, R. A. (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). II. A review of histopathological aspects. Brain Pathol. 6, 115-120.
25. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I., & Masters, C. L. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866.
26. Melchor, J. P., & Van Nostrand, W. E. (2000) Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells. J. Biol. Chem. 275, 9782-9791.
27. Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B., & Ghiso, J. (2000) Substitutions at codon 22 of Alzheimer's A{beta} peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275, 27110-27116.
28. Pahlman, S., Ruusala, A. I., Abrahamsson, L., Mattsson, M. E., & Esscher, T. (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbol-ester-induced differentiation. Cell Differ. 14, 135-144.
29. Pike, C. J., Overman, M. J., & Cotman, C. W. (1995) Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J. Biol. Chem. 270, 23895-23898.
30. Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367-368.
31. Roks, G., van Harskamp, F., De, K. I., Cruts, M., De Jonghe, C., Kumar-Singh, S., Tibben, A., Tanghe, H., Niermeijer, M. F., Hofman, A., van Swieten, J. C., Van Broeckhoven, C., & van Duijn, C. M. (2000) Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 123, 2130-2140.
32. Saido, T. C., Yamao-Harigaya, W., Iwatsubo, T., & Kawashima, S. (1996) Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci. Lett. 215, 173-176.
33. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends. Cell Biol. 8, 447-453.
34. Sian, A. K., Frears, E. R., El Agnaf, O. M., Patel, B. P., Manca, M. F., Siligardi, G., Hussain, R., & Austen, B. M. (2000) Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types. Biochem. J. 349, 299-308.
35. Soriano, S., Lu, D. C., Chandra, S., Pietrzik, C. U., & Koo, E. H. (2001) The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. J. Biol. Chem. 276, 29045-29050.
36. Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, W., Wehnert, A., Vegter-Van, D. V., & Roos, R. A. (1990) Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248, 1120-1122.
37. Walsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., & Teplow, D. B. (2001) In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692 β Gly) Alzheimer's disease. Biochem. J. 355, 869-877.
38. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
39. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) Amyloid beta-protein fibrillogenesis: Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
40. Wang, Z., Natte, R., Berliner, J. A., van Duinen, S. G., Vinters, H. V., & Rosenblum, W. I. (2000) Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 31, 534-538.
41. Wisniewski, T., Ghiso, J., & Frangione, B. (1991) Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 180, 1528.